Astraveus Secures €7.1M Non-dilutive Funding from the French State

For further information, please contact:  Astraveus SASJérémie Laurent, Chief Executive Officerjeremie@astraveus.com  For further information, please contact:    Astraveus SAS Jérémie Laurent, Chief Executive Officerjeremie@astraveus.com   About Astraveus:    Astraveus is aParis -based biotech company dedicated to making cell therapies with maximized quality at order-of-magnitude lower cost. With the unique Lakhesys Benchtop Cell Factory™, Astraveus provides bioprocessing innovation...

PARIS, 19/12/2024 (informazione.it - comunicati stampa - salute e benessere)

 
Astraveus SAS
Jérémie Laurent, Chief Executive Officer
jeremie@astraveus.com  

 

Astraveus is a Paris -based biotech company dedicated to making cell therapies with maximized quality at order-of-magnitude lower cost. With the unique Lakhesys Benchtop Cell Factory™, Astraveus provides bioprocessing innovation at the cellular level, utilizing cutting-edge microfluidic technology to enhance process optimization and scalability from pre-clinical to commercial manufacturing.

Founded in 2016 by Jérémie Laurent at the Saint-Louis Hospital in Paris , a prestigious hub for leading cell therapy research, Astraveus is committed to revolutionize the development and manufacturing of cell therapies and aspires to make these innovative treatments accessible to everyone in need, thereby enabling a healthier tomorrow.

www.astraveus.com
www.bpifrance.com

View original content: https://www.prnewswire.co.uk/news-releases/astraveus-secures-7-1m-non-dilutive-funding-from-the-french-state-302336549.html